Cognitive Versus Software-based Fusion Targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION)
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Cognitive Versus Software-based Fusion Targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). // European Urology. – URL: https://www.sciencedirect.com/science/article/pii/S0302283826022438?dgcid=rss_sd_all
Cognitive Versus Software-based Fusion Targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION). European Urology. https://www.sciencedirect.com/science/article/pii/S0302283826022438?dgcid=rss_sd_all
“Cognitive Versus Software-based Fusion Targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION).” European Urology.
@article{article45462,
title = {Cognitive Versus Software-based Fusion Targeted Biopsy for the Diagnosis of Clinically Significant Prostate Cancer: A Multicenter, Randomized, Noninferiority Trial (IMAGINATION)},
journal = {European Urology},
url = {https://www.sciencedirect.com/science/article/pii/S0302283826022438?dgcid=rss_sd_all}
}